| | Call Details | Covidien Ltd. Earnings Conference Call (Q2 2008) Tue,
May 6, 2008, 8:30 am Eastern
| | About Covidien Ltd.
(NYSE:COV) |
| | Covidien, Ltd. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide. It operates through four segments: Medical Devices, Pharmaceutical Products, Imaging Solutions, and Medical Supplies. The Medical Devices segment provides endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, vascular devices, sharpsafety products, clinical care products, and other medical device products. The Pharmaceutical Products segment offers dosage pharmaceuticals, active pharmaceutical ingredients, and specialty chemicals. The Imaging Solutions segment provides radiopharmaceuticals, such as radioactive isotopes and associated pharmaceutical products used for the diagnosis and treatment of disease; and contrast products, including contrast delivery systems and contrast agents. The Medical Supplies segment offers nursing care products, including woundcare products; medical surgical products, such as operating room supply products and related accessories, electrodes, and chart paper product lines; and original equipment manufacturer products, which include medical supplies, such as needles and syringes; and incontinence products. Covidiens customers include hospitals, surgi-centers, imaging centers, alternate site facilities, drug manufacturers, and retailers. The company was incorporated in 2000 and is based in Hamilton, Bermuda. |
| More
Info:
Quote
|
News
|
Profile
|
Reports
|
Research
|
Insider
|
Financials
|
Analyst Ratings |
|